Future research in ILD primarily focuses on utilizing specific mutant SFTPC gene mouse models to examine the impact of USP11 inhibitors, thereby enhancing comprehension of the disease's genetic basis and facilitating the development of targeted therapies. Here, SFTPC is linked to interstitial lung disease.